Published in Gene Therapy Weekly, December 12th, 2002
It is not uncommon for cancers to become drug-resistant at some point during chemotherapy, according to Matthes Huesker and colleagues, University Hospital Freiburg, Freiburg, Germany.
"The multidrug resistance (MDR) transporters MDR1-P-glycoprotein and MRP2 (multidrug-associated protein 2) are expressed in almost 50% of human cancers, including hepatocellular carcinomas (HCCs)," Huesker and coauthors explained in Hepatology.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.